west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "游蓁" 4 results
  • Clinical Comparative Analysis of LC+LCBDE and ERCP/EST+LC for Cholecystolithiasis with Choledocholithiasis Patients with Obstructive Jaundice

    Objective To discuss the therapeutic effect and safety of laparoscopic cholecystectomy plus laparoscopiccommon bile duct exploration (LC+LCBDE) and endoscopic retrograde cholangiopancreatography/endoscopic sphincte-rotomy plus LC (ERCP/EST+LC) for cholecystolithiasis with choledocholithiasis patients with obstructive jaundice. Methods The clinical data of cholecystolithiasis with choledocholithiasis patients with obstructive jaundice from January2011 to June 2012 were analyzed retrospectively. During this period, 48 patients were treated by LC+LCBDE (LC+LCBDE group), and 76 patients by ERCP/EST+LC (ERCP/EST+LC group). Results ①There were no statistical significances in the age, gender, preoperative total bilirubin, alanine aminotransferase, number and maximum diameter of common bile duct stone, and internal diameter of common bile duct in two groups (P>0.05). ②No perioperative mortality occurred and no significant differences were observed in terms of stone clearance from the common bile duct, postoperative morbidity, and conversion to open surgery in two groups (P>0.05). However, the operative time and post-operative hospital stay in the LC+LCBDE group were shorter than those in the ERCP/EST+LC group (P<0.05). In addi-tion, the costs of surgical procedure and hospitalization charges in the LC+LCBDE group were less than those in the ERCP/EST+LC group (P<0.05). Conclusions Both LC+LCBDE and ERCP/EST+LC are safe and effective therapies forcholecystolithiasis with choledocholithiasis patients with obstructive jaundice. However, LC+LCBDE is better for pati-ents’ recovery and cost effective. Especially for patients with common bile duct>1.0cm in diameter or with multiple common bile duct stones, LC+LCBDE is the best choice. To sum up, the choice of minimally invasive treatment must be individualized according to the patient’s condition and the availability of local resources.

    Release date:2016-09-08 10:23 Export PDF Favorites Scan
  • Primary Closure Versus T-Tube Drainage after Laparoscopic Exploration of Common Bile Duct

    目的 比较腹腔镜胆道探查术后胆总管一期缝合与T管引流两种术式治疗胆囊结石合并胆管结石的疗效。方法 回顾性分析2011年4月至2012年5月期间笔者所在科室收治的因胆囊结石合并胆管结石接受腹腔镜胆囊切除+胆道探查治疗的109例患者的临床资料,其中58例行T管引流,51例行一期胆总管缝合。比较2组患者的手术时间、住院时间、治疗费用、术后恢复正常生活时间以及手术并发症情况。结果 T管引流组术后发生胆瘘2例(3.4%),一期缝合组术后发生胆瘘1例(2.0%),其差异无统计学意义(P>0.05)。2组患者的手术时间、住院时间及住院治疗费用的差异均无统计学意义(P>0.05)。一期缝合组患者术后恢复正常生活时间为(7.2±1.1) d,短于T管引流组的(28.2±2.7)d(P=0.001)。结论 经腹腔镜胆道探查术后一期胆总管缝合是安全可行的,可缩短患者的康复时间,提高患者围手术期生活质量。

    Release date:2016-09-08 10:25 Export PDF Favorites Scan
  • The Effect of Oral Xiaoyan Lidan Tablets on The Bile Composition in Patients with Intrahepatic Bile Duct Stones

    ObjectiveTo observe the effects of oral Xiaoyan Lidan tablets(XYLDT) on the bile composition(total bile acids, cholesterol, phospholipids) in patients with intrahepatic duct stones after common bile duct exploration(CBDE) with T tube drainage, to explore its possible preventive effects on stone recurrence. MethodsForty consecutive patients with intrahepatic bile duct stones who underwent CBDE with T tube drainage were randomly divided into experi mental group and control group. XYLDT were administrated at day 4 after surgery in experimental group(n=20), while none of medication were given in control group(n=20). 2 mL of bile was collected through T tube in both groups at day 1, 2, 3, 7, 14, and 21 postoperatively. Total bile acids(TBA), cholesterol(CHO), and phospholipids(PLIP) in bile were measured, and TBA/CHO ratio and PLIP/CHO ratio were calculated respectively. The results were statistical analyzed. ResultsThe demographic data in both groups including age, gender, height, weight, preoperative concomitant diseases, operative time, postoperative complications, hospital stays, serum total bilirubin, direct bilirubin, alanine aminotransferase(ALT), aspartate aminotransferase(AST), and amylase were not significantly different(P > 0.05). The measurements of TBA, CHO, PLIP, and the ratio of TBA/CHO and PLIP/CHO in bile were not significant on day 1, 2, and 3 after surgery in both groups(P > 0.05). In experimental group, the TBA, CHO, and PLIP on day 7, 14, and 21 after surgery were significantly increased compared with the control group(P < 0.05). The ratio of TBA/CHO on day 7, 14, and 21 was 2.17±0.29, 2.29±0.44, and 2.59±0.58, the ratio of PLIP/CHO was 2.03±0.68, 2.84±0.64, and 2.86±0.77, respectively, which were also significantly increased compared with the control group(P < 0.05). ConclusionsOral XYLDT can increase the secretion of TBA, CHO, and PLIP, elevate the TBA/CHO and PLIP/CHO ratio, and change the bile composition which may increase the dissolution of cholesterol in the bile. Presumably, oral XYLDT may have preventive effects in the recurrence of intrahepatic bile duct stones.

    Release date: Export PDF Favorites Scan
  • The Advantage of Ambulatory Laparoscopic Cholecystectomy

    ObjectiveTo investigate the feasibility, safety, cost, and patient satisfaction of ambulatory laparo-scopic cholecystectomy(ALC). MethodsThe clinical data of patients who divided into ALC group(678 cases) and in-patient laparoscopic cholecystectomy(IPLC) group(1 534 cases) in our hospital from April 2011 to December 2012 were retrospectively analyzed. The operative time, conversion rate, complication rate, hospitalization time, cost of hospi-talization, rehospitalization rate, and patient satisfaction were analyzed and evaluated. ResultsThere were no significant differences of the operative time, postoperative complication rate, and rehospitalization rate between the 2 groups(P > 0.05). The conversion rate(0.44%), and hospitalization time[(1.2±0.5)d] of the ALC group were significantly lower or shorter than those of IPLC group[3.19%, (4.8±1.3) d], P < 0.05. The direct, indirect health care costs, and the total costs of the ALC group were (6 555.6±738.7), (230.0±48.0), and (8 856.0±636.0) yuan, respec-tively; and lower than those of the IPLC group[(7 863.71, 014.6), (973.0±136.5), and(8 856.0±636.0)yuan], P < 0.05. ConclusionALC is safe and feasible, and could shorten the hospitalization time, lower the medical cost, speed up the bed turnover, and increase the efficiency in the use of health resource.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content